MesotheliomaPhase 1NCT06885697
TNhYP218 CAR T Cells
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2
What the film says
This trial is for locally advanced or metastatic non-small cell lung cancer, in adults whose daily activity is limited, called performance status 2.
The idea: pair immunotherapy with a single chemotherapy drug. Pembrolizumab is given with either pemetrexed or nab-paclitaxel, every 21 days, as first treatment. The study enrolls patients with stage three C or stage four disease.
This pilot phase 1 study asks whether the combination is tolerable, and plans 60 patients. At the University of Rochester in New York, Megan Baumgart leads it.
Public record; not medical advice.
Sources behind this film
Locally advanced or metastatic NSCLC, adults with performance status 2; Pembrolizumab with pemetrexed or nab-paclitaxel, every 21 days, first treatment; Pilot phase 1; tolerable; 60 patients; University of Rochester, New York; Megan Baumgart (+1 more lines)
The drug
500 mg/m2 day 1 of 21 day cycle (for non-squamous only)
100 mg/m2 days 1,8 of 21 day cycle x 4 cycles
The study
The purpose of this study is to understand if treatment with one chemotherapy medication combined with immune therapy (pembrolizumab) is tolerable and effective for patients with lung cancer and performance status of 2 (PS2), which means you have limitations in carrying out certain activities or spend up to half of your day resting.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.